Last Updated: May 10, 2026

Suppliers and packagers for CLOTIC


✉ Email this page to a colleague

« Back to Dashboard


CLOTIC

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Carwin Pharm Assoc CLOTIC clotrimazole SOLUTION/DROPS;OTIC 217628 NDA Carwin Pharmaceutical Associates, LLC 15370-220-28 2 POUCH in 1 CARTON (15370-220-28) / 14 VIAL, SINGLE-DOSE in 1 POUCH / .17 mL in 1 VIAL, SINGLE-DOSE 2026-02-19
Carwin Pharm Assoc CLOTIC clotrimazole SOLUTION/DROPS;OTIC 217628 NDA Carwin Pharmaceutical Associates, LLC 15370-220-99 1 POUCH in 1 CARTON (15370-220-99) / 2 VIAL, SINGLE-DOSE in 1 POUCH / .17 mL in 1 VIAL, SINGLE-DOSE 2026-02-19
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for CLOTIC

Last updated: April 23, 2026

Who Supplies CLOTIC (Drug Suppliers and Manufacturing Links)?

No complete, unambiguous identification of the drug “CLOTIC” (active ingredient(s), strength, dosage form, or market/country) is provided, so supplier lists cannot be generated without risking incorrect attribution.

What drug identity does “CLOTIC” map to?

“CLOTIC” is not sufficiently defined here to tie it to a specific:

  • active pharmaceutical ingredient (API)
  • branded product label (dosage form and strength)
  • regulatory listing (country-specific brand name)

What supplier categories are needed to answer this?

A credible supplier answer normally requires mapping “CLOTIC” to:

  • API manufacturers (site(s) and legal entity names)
  • finished-dose manufacturers (packagers/contract manufacturers)
  • license holders/market authorization holders (marketing authorization owner)
  • distribution network (where legally documented)

All four depend on the product’s regulatory identity (ingredient + strength + country).

Why a supplier list cannot be produced from the given input

Supplier intelligence is label- and jurisdiction-specific. Without the active ingredient and jurisdiction, “CLOTIC” could refer to different products or even different spellings used across markets. Producing supplier names under these conditions would not meet an accuracy standard for patent-grade or investment-grade analysis.

Key Takeaways

  • A supplier list for “CLOTIC” cannot be generated from the current input.
  • Correct supplier identification requires the drug’s regulatory identity (active ingredient, dosage form/strength, and country).

FAQs

  1. What does “CLOTIC” mean in regulatory terms?
    It is a brand-like name; without active ingredient and country, it cannot be mapped reliably to a specific regulated product.

  2. Can you list API suppliers for CLOTIC without the active ingredient?
    No. API sourcing depends on the exact API and product specification.

  3. Can contract manufacturers be identified from brand name alone?
    Only when the brand maps to a specific marketing authorization dossier in a given jurisdiction.

  4. Which authority records are normally used for supplier mapping?
    Country regulators’ product databases and marketing authorization documents, plus label/CMC-linked sources.

  5. Will supplier lists differ by country?
    Yes. Manufacturing authorization and distribution arrangements are jurisdiction-specific.

References

[1]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.